Patent Portfolio

Prophylactic or therapeutic agent for FGFR3 disease

Ref. No. AJ175
Appl. No.
(filing date)
PCT/JP2017/013524(2017/3/31)
Pub. No.
(Pub. date)
WO2017/170981(2017/10/5)
Priority claim No.
(Priority date)

JP2016-074721 (2016/04/01)

Patent No.

-

Inventor TSUMAKI, Noriyuki, etc.
Assignee Kyoto University
Title of Invention Prophylactic or therapeutic agent for FGFR3 disease
Abstract

The present invention provides a therapeutic and/or prophylactic agent for FGFR3 disease, which contains at least one compound selected from the group consisting of metformin, a farnesyl transferase inhibitor, a geranylgeranyl transferase inhibitor and a Rock inhibitor, as an active ingredient. This invention has been completed as a result of drug candidate screening using cartilage tissues differentiated from iPS cells derived from FGFR3 patients.

Comments

-

Updated date 2019/6/13
Information
(External link)
https://www.j-platpat.inpit.go.jp/c1800/PU/WO-A-2017-170981/16F9F492A3F7A3D78E6EB0F03F9B878BE5ECD4ADB217C433FDB540EDDE03AACB/50/en